Vinay Prasad is divisive, opinionated — and usually right
A version of this piece first appeared in Sensible Medicine. Vinay Prasad, Marty Makary, and Adam Cifu, among…
Vinay Prasad departs FDA | STAT
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
FDA seeks to classify 7-OH as Schedule 1 drug amid addiction concerns
WASHINGTON (TNND) — The Trump administration is calling for the compound 7-OH, a popular by-product of the Kratom…
Scientists discover two drugs already approved by the FDA can reverse Alzheimer’s
Two drugs already approved by the FDA for cancer treatment may hold the key to reversing Alzheimer’s disease…
FDA panel weighs ban on fluoride tablets and drops for kids
The Food and Drug Administration (FDA) said it plans to ban fluoride tablets and drops, which have long…
As Sarepta, FDA tangle over Duchenne therapy, families are caught in the middle
Jennifer Hill Blair recognized the Cincinnati number on her buzzing phone and slipped out of the school meeting,…
FDA upgrades recall for 160K bottles of commonly prescribed medication
WASHINGTON (WKRC) – The Food and Drug Administration (FDA) has upgraded a recall of commonly prescribed medication. The…
Sarepta Therapeutics’ Elevidys faces ‘arduous’ path back to market
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Within a year, RFK wants to help you treat depression with psychedelics, LSD and ecstasy
For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering substances like LSD and ecstasy should…
Weight-Loss Drugs Telehealth Platform Hims & Hers Hit With New Lawsuit
A stockholder has filed a derivative lawsuit against the board of directors of Hims & Hers, the fast‑growing…
New recall of injected penicillin may put gains against syphilis in peril
Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting…
FDA Rejects CAPR’s Cell Therapy BLA for Genetic Disorder, Stock Tanks
Shares of Capricor Therapeutics CAPR tanked 33% on Friday after it announced that the FDA issued a complete…